glp-1 before pregnancy use during early may not increase risk of major adverse outcomes Discontinuing GLP-1 Receptor Agonist Use

Recently, further studies revealed that optogenetic activation of PPG neurons in the GCL generates biphasic inhibition-excitation response in MCs

It can be prescribed off-label to promote weight loss in some cases

The evidence base for probiotics in this context does not meet the standards required for inclusion in clinical guidelines, and NICE emphasises multicomponent lifestyle interventions alongside licensed pharmacological options when appropriate

Deficiency is common and worsens recovery outcomes

Microdosing or starting with a l ower dose may help to prevent gastrointestinal side effects

But some GLP-1 medications are FDA-approved to reduce the risk of major cardiovascular events, such as heart attack and stroke, in certain people with Type 2 diabetes or obesity